NO20072499L - Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser - Google Patents

Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Info

Publication number
NO20072499L
NO20072499L NO20072499A NO20072499A NO20072499L NO 20072499 L NO20072499 L NO 20072499L NO 20072499 A NO20072499 A NO 20072499A NO 20072499 A NO20072499 A NO 20072499A NO 20072499 L NO20072499 L NO 20072499L
Authority
NO
Norway
Prior art keywords
methods
receptor binding
compositions
applications
melanocortin receptor
Prior art date
Application number
NO20072499A
Other languages
English (en)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of NO20072499L publication Critical patent/NO20072499L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Melanocortin reseptorbindende antistoff etterlikner polypeptider er beskrevet. Polynukleotider som koder for disse polypeptidene, celler omfattende disse polynukleotidene eller som uttrykker antistoff etterliknerne, fremgangsmåter for å fremstille og anvende de foregående er også beskrevet.
NO20072499A 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser NO20072499L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
NO20072499L true NO20072499L (no) 2007-07-16

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072499A NO20072499L (no) 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Country Status (28)

Country Link
US (1) US20060105951A1 (no)
EP (1) EP1812046B1 (no)
JP (1) JP2008517605A (no)
KR (1) KR101255140B1 (no)
CN (1) CN101437540B (no)
AT (1) ATE501731T1 (no)
AU (1) AU2005299440B2 (no)
BR (1) BRPI0518411A2 (no)
CA (1) CA2585287A1 (no)
CY (1) CY1111486T1 (no)
DE (1) DE602005026970D1 (no)
DK (1) DK1812046T3 (no)
EA (1) EA200700944A1 (no)
EC (1) ECSP077416A (no)
ES (1) ES2363023T3 (no)
HR (1) HRP20110405T1 (no)
IL (1) IL182683A0 (no)
MA (1) MA28943B1 (no)
ME (1) ME01234B (no)
MX (1) MX2007004974A (no)
NO (1) NO20072499L (no)
PL (1) PL1812046T3 (no)
PT (1) PT1812046E (no)
RS (1) RS51789B (no)
SI (1) SI1812046T1 (no)
TN (1) TNSN07157A1 (no)
WO (1) WO2006047535A2 (no)
ZA (1) ZA200704260B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) * 2008-06-09 2010-08-04 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (en) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt) 2009-06-08 2022-02-08 Palatin Technologies, Inc Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005818A (es) * 1998-12-09 2003-07-21 Eleanor Rooseveltl Inst Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
WO2004002417A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) * 2002-06-28 2007-07-10 Centocor, Inc. Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
EP1750754A4 (en) * 2004-03-31 2010-09-22 Centocor Ortho Biotech Inc HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES

Also Published As

Publication number Publication date
WO2006047535A2 (en) 2006-05-04
ATE501731T1 (de) 2011-04-15
HK1106445A1 (en) 2008-03-14
EP1812046B1 (en) 2011-03-16
PT1812046E (pt) 2011-06-28
SI1812046T1 (sl) 2011-06-30
ZA200704260B (en) 2009-03-25
CA2585287A1 (en) 2006-05-04
US20060105951A1 (en) 2006-05-18
WO2006047535A3 (en) 2008-09-04
PL1812046T3 (pl) 2011-08-31
IL182683A0 (en) 2007-09-20
RS51789B (sr) 2011-12-31
BRPI0518411A2 (pt) 2008-11-18
KR101255140B1 (ko) 2013-04-22
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
HRP20110405T1 (hr) 2011-06-30
AU2005299440B2 (en) 2011-12-15
DK1812046T3 (da) 2011-06-06
CN101437540B (zh) 2012-12-19
CN101437540A (zh) 2009-05-20
ECSP077416A (es) 2007-05-30
JP2008517605A (ja) 2008-05-29
MA28943B1 (fr) 2007-10-01
ME01234B (me) 2013-06-20
KR20070085416A (ko) 2007-08-27
DE602005026970D1 (de) 2011-04-28
EP1812046A2 (en) 2007-08-01
MX2007004974A (es) 2007-10-17
TNSN07157A1 (en) 2008-11-21
EP1812046A4 (en) 2009-11-11
ES2363023T3 (es) 2011-07-19
AU2005299440A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
ZA200704260B (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (en) Fc variants with optimized fc receptor binding properties
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
DK1864132T3 (da) Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
WO2006009888A3 (en) C-met kinase binding proteins
DK2574640T3 (da) Bindemidler og dermed fremstillede materialer
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
EP1718751A4 (en) NEW BACILLUS THURINGIENSIS CRYSTAL POLYPEPTIDES, POLYNUCLEOTIDES, AND COMPOSITIONS THEREOF
DK1871805T3 (da) Antigenbindende molekyler der binder egfr, vektorer der koder derfor, og anvendelser deraf
ZA200803989B (en) Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2007079218A3 (en) Metalloproteinase binding proteins
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
NO20091181L (no) Anti-C5AR-antistoffer med forbedrede egenskaper
WO2008154547A3 (en) Spider silk dragline polynucleotides, polypeptides and methods of use thereof
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
EA200800301A1 (ru) Протеины, связывающие il-6
DK1844072T3 (da) MHC-oligomer og fremgangsmåde til fremstilling deraf
WO2007044083A3 (en) Evolved interferon-alpha polypeptides
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
MX296535B (es) Enzima laccasa novedosa y uso de la misma.
MX2007011411A (es) Interaccion rage/diaphanous y composiciones relacionadas y metodos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application